J Neurol Surg A Cent Eur Neurosurg 2014; 75(04): 282-288
DOI: 10.1055/s-0033-1358611
Original Article
Georg Thieme Verlag KG Stuttgart · New York

Epilepsy, Headache, and Quality of Life after Resection of Cerebral Arteriovenous Malformations

Benjamin Rohn
1   Department of Neurosurgery, Heinrich-Heine-Universität, Düsseldorf, Germany
,
Daniel Haenggi
1   Department of Neurosurgery, Heinrich-Heine-Universität, Düsseldorf, Germany
,
Nima Etminan
1   Department of Neurosurgery, Heinrich-Heine-Universität, Düsseldorf, Germany
,
Mathias Kunz
2   Department of Neurosurgery, Ludwig-Maximilians-Universität, Munich, Germany
,
Bernd Turowski
3   Division of Neuroradiology, Heinrich-Heine-Universität, Düsseldorf, Germany
,
Hans-Jakob Steiger
1   Department of Neurosurgery, Heinrich-Heine-Universität, Düsseldorf, Germany
› Author Affiliations
Further Information

Publication History

11 January 2013

09 August 2013

Publication Date:
12 March 2014 (online)

Abstract

Background In ruptured and unruptured arteriovenous malformations (AVMs), bleeding and re-bleeding rate and efficacy of microsurgical, endovascular, and radiosurgical treatment to prevent hemorrhage are well known. Uncertainty exists concerning the benefit of therapy with regard to headache, epilepsy, and quality of life (QoL) in unruptured AVMs. The objective of the present study was to gain long-term follow-up information after microsurgical AVM resection, in particular with regard to epilepsy, headache, and QoL.

Methods A series of 110 patients with cerebral AVM, surgically treated between 1994 and 2009, were analyzed. Epidemiological, sociodemographic, and disease-related characteristics were extracted from the patient records. A detailed follow-up interview was possible with 51 patients after a median of 7 ± 5 years after surgery. A structured telephone interview using the Short Form (SF)-36 for QoL assessment was performed. In addition, specific questions regarding epilepsy and seizure outcome as well as independence and professional activity were asked.

Results Hemorrhage led to hospital admission in 58.2% patients; 35.5% were admitted with epileptic seizures and 24.5% of patients reported chronic headaches. On the Spetzler-Martin scale, 26.0% were grade 1, 38% grade 2, 25% grade 3, and 11% grade 4. Preoperative embolization was performed in 43.6%. Treatment-associated new neurological deficits at the time of discharge from the hospital occurred in 25.5%. At the time of follow-up, 94.2% of the patients were completely independent (Barthel index of 100). 64.7% of the patients with preoperative epilepsy were free of disabling seizures or rarely have disabling seizures (Engel class 1 and 2), 16.7% reported no significant change, and 17.6% reported worsening. A total of 17.6% patients in whom epilepsy was not known at the time of AVM treatment reported new seizures after therapy, all but one had hemorrhage. 38.5% of patients with preoperative chronic headache reported improvement, 53.8% no change, and 7.7% deterioration. Regarding SF-36 QoL scores, a statistically significant difference from the age-matched German norm values was found in the dimensions Bodily Pain (p = 0.03) and Emotional Role Function (p = 0.04). There was a trend for lower physical and mental sum scores in patients undergoing emergency surgery.

Conclusions SF-36–based QoL scores after treatment of AVM differ little from the age-matched German averages. The long-term results regarding chronic epilepsy and chronic headache need further analysis.

 
  • References

  • 1 Brown Jr RD, Flemming KD, Meyer FB, Cloft HJ, Pollock BE, Link ML. Natural history, evaluation, and management of intracranial vascular malformations. Mayo Clin Proc 2005; 80 (2) 269-281
  • 2 Brown Jr RD, Wiebers DO, Torner JC, O'Fallon WM. Incidence and prevalence of intracranial vascular malformations in Olmsted County, Minnesota, 1965 to 1992. Neurology 1996; 46 (4) 949-952
  • 3 Brown Jr RD, Wiebers DO, Forbes G , et al. The natural history of unruptured intracranial arteriovenous malformations. J Neurosurg 1988; 68 (3) 352-357
  • 4 Choi JH, Mast H, Sciacca RR , et al. Clinical outcome after first and recurrent hemorrhage in patients with untreated brain arteriovenous malformation. Stroke 2006; 37 (5) 1243-1247
  • 5 Davidson AS, Morgan MK. How safe is arteriovenous malformation surgery? A prospective, observational study of surgery as first-line treatment for brain arteriovenous malformations. Neurosurgery 2010; 66 (3) 498-504; discussion 504–505
  • 6 Duong DH, Young WL, Vang MC , et al. Feeding artery pressure and venous drainage pattern are primary determinants of hemorrhage from cerebral arteriovenous malformations. Stroke 1998; 29 (6) 1167-1176
  • 7 Hartmann A, Mast H, Choi JH, Stapf C, Mohr JP. Treatment of arteriovenous malformations of the brain. Curr Neurol Neurosci Rep 2007; 7 (1) 28-34
  • 8 Hartmann A, Mast H, Mohr JP , et al. Morbidity of intracranial hemorrhage in patients with cerebral arteriovenous malformation. Stroke 1998; 29 (5) 931-934
  • 9 McInerney J, Gould DA, Birkmeyer JD, Harbaugh RE. Decision analysis for small, asymptomatic intracranial arteriovenous malformations. Neurosurg Focus 2001; 11 (5) e7
  • 10 Ondra SL, Troupp H, George ED, Schwab K. The natural history of symptomatic arteriovenous malformations of the brain: a 24-year follow-up assessment. J Neurosurg 1990; 73 (3) 387-391
  • 11 Spetzler RF, Martin NA. A proposed grading system for arteriovenous malformations. J Neurosurg 1986; 65 (4) 476-483
  • 12 Stapf C, Mast H, Sciacca RR , et al. Predictors of hemorrhage in patients with untreated brain arteriovenous malformation. Neurology 2006; 66 (9) 1350-1355
  • 13 van Beijnum J, van der Worp HB, Buis DR , et al. Treatment of brain arteriovenous malformations: a systematic review and meta-analysis. JAMA 2011; 306 (18) 2011-2019
  • 14 Stapf C. The rationale behind “A Randomized Trial of Unruptured Brain AVMs” (ARUBA). Acta Neurochir Suppl (Wien) 2010; 107: 83-85
  • 15 Bullinger M. Assessment of health related quality of life with the SF-36 Health Survey [in German]. Rehabilitation (Stuttg) 1996; 35 (3) XVII-XXVII; quiz XXVII–XXIX
  • 16 Radoschewski M, Bellach BM. The SF-36 in the Federal Health Survey—possibilities and requirements for application at the population level [in German]. Gesundheitswesen 1999; 61 (Spec No): S191-S199
  • 17 Frizzel RT, Fisher III WS. Cure, morbidity, and mortality associated with embolization of brain arteriovenous malformations: a review of 1246 patients in 32 series over a 35-year period. Neurosurgery 1995; 37 (6) 1031-1039; discussion 1039–1040
  • 18 Heros RC, Korosue K, Diebold PM. Surgical excision of cerebral arteriovenous malformations: late results. Neurosurgery 1990; 26 (4) 570-577; discussion 577–578
  • 19 Kim LJ, Albuquerque FC, Spetzler RF, McDougall CG. Postembolization neurological deficits in cerebral arteriovenous malformations: stratification by arteriovenous malformation grade. Neurosurgery 2006; 59 (1) 53-59; discussion 53–59
  • 20 Loh Y, Duckwiler GR ; Onyx Trial Investigators. A prospective, multicenter, randomized trial of the Onyx liquid embolic system and N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations. Clinical article. J Neurosurg 2010; 113 (4) 733-741
  • 21 Schaller C, Schramm J. Microsurgical results for small arteriovenous malformations accessible for radiosurgical or embolization treatment. Neurosurgery 1997; 40 (4) 664-672; discussion 672–674
  • 22 Sisti MB, Kader A, Stein BM. Microsurgery for 67 intracranial arteriovenous malformations less than 3 cm in diameter. J Neurosurg 1993; 79 (5) 653-660
  • 23 Shin AY, Porter PJ, Wallace MC, Naglie G. Quality of life of stroke in younger individuals. Utility assessment in patients with arteriovenous malformations. Stroke 1997; 28 (12) 2395-2399
  • 24 van der Schaaf IC, Brilstra EH, Rinkel GJ, Bossuyt PM, van Gijn J. Quality of life, anxiety, and depression in patients with an untreated intracranial aneurysm or arteriovenous malformation. Stroke 2002; 33 (2) 440-443
  • 25 Buijs JE, Greebe P, Rinkel GJ. Quality of life, anxiety, and depression in patients with an unruptured intracranial aneurysm with or without aneurysm occlusion. Neurosurgery 2012; 70 (4) 868-872
  • 26 Lai EH, Lun SL. Impact on the quality of life of patients with arteriovenous malformations during the latent interval between gamma knife radiosurgery and lesion obliteration. J Neurosurg 2002; 97 (5, Suppl): 471-473
  • 27 Yang SY, Paek SH, Kim DG, Chung HT. Quality of life after radiosurgery for cerebral arteriovenous malformation patients who present with seizure. Eur J Neurol 2012; 19 (7) 984-991
  • 28 Eisenschenk S, Gilmore RL, Friedman WA, Henchey RA. The effect of LINAC stereotactic radiosurgery on epilepsy associated with arteriovenous malformations. Stereotact Funct Neurosurg 1998; 71 (2) 51-61
  • 29 Ghossoub M, Nataf F, Merienne L , et al. Evolution of epileptic seizures associated with cerebral arteriovenous malformations after radiosurgery [in French]. Neurochirurgie 2001; 47 (2–3 Pt 2): 344-349
  • 30 Hoh BL, Chapman PH, Loeffler JS, Carter BS, Ogilvy CS. Results of multimodality treatment for 141 patients with brain arteriovenous malformations and seizures: factors associated with seizure incidence and seizure outcomes. Neurosurgery 2002; 51 (2) 303-309; discussion 309–311
  • 31 Schäuble B, Cascino GD, Pollock BE , et al. Seizure outcomes after stereotactic radiosurgery for cerebral arteriovenous malformations. Neurology 2004; 63 (4) 683-687
  • 32 Dehdashti AR, Thines L, Willinsky RA , et al. Multidisciplinary care of occipital arteriovenous malformations: effect on nonhemorrhagic headache, vision, and outcome in a series of 135 patients. Clinical article. J Neurosurg 2010; 113 (4) 742-748
  • 33 Ghossoub M, Nataf F, Merienne L , et al. Course of headaches associated with cAVMs after radiosurgery [in French]. Neurochirurgie 2001; 47 (2–3 Pt 2): 350-354
  • 34 Kurita H, Ueki K, Shin M , et al. Headaches in patients with radiosurgically treated occipital arteriovenous malformations. J Neurosurg 2000; 93 (2) 224-228